GSA CAPITAL PARTNERS LLP

Position in OVID — Ovid Therapeutics Inc.

CIK 1362033 LONDON, X0

Position in OVID

as of Mar 31, 2026 · filed May 8, 2026 Compact

Position Value

$275,211

+$98,627 QoQ

Shares Held

123,969

+14.4% QoQ

Ownership

0.063%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

GSA CAPITAL PARTNERS LLP holds $104,909,103 across 164 Biotechnology names.

#	Ticker	Company	Shares	Value (USD)
1	IOVA	Iovance Biotherapeutics, Inc.	655,318	$2,726,122
2	IMVT	Immunovant, Inc.	65,267	$2,514,737
3	GOSS	Gossamer Bio, Inc.	14,986,947	$2,472,846
4	AXSM	Axsome Therapeutics, Inc.	9,419	$2,305,488
5	CABA	Cabaletta Bio, Inc.	668,563	$2,079,230
6	MLTX	MoonLake Immunotherapeutics	106,695	$2,077,351
7	ATYR	aTYR PHARMA INC	3,454,863	$2,062,553
8	CORT	Corcept Therapeutics Inc	23,257	$2,022,196

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$275,211	123,969	+14.4%	Shares	Sole	2026-05-08
2025-12-31	$176,584	108,334	-59.3%	Shares	Sole	2026-02-06
2025-09-30	$345,790	265,993	-64.2%	Shares	Sole	2025-11-07
2025-06-30	$244,922	742,190	+68.6%	Shares	Sole	2025-07-22
2025-03-31	$137,312	440,103	+256.1%	Shares	Sole	2025-05-08
2024-12-31	$115,426	123,583	-52.6%	Shares	Sole	2025-02-07
2024-09-30	$307,400	260,509	+118.0%	Shares	Sole	2024-11-05
2024-06-30	$91,900	119,507	+57.5%	Shares	Sole	2024-08-15
2021-03-31	$305,069	75,888	-60.4%	Shares	Sole	2021-05-10
2020-12-31	$443,134	191,833	+237.3%	Shares	Sole	2021-02-03
2020-09-30	$326,456	56,874	—	Shares	Sole	2020-11-06
No filing history on record for this holder in this stock.